Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
The Oncology Institute, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2028 | $1.09B | $1.06B - $1.11B | -$188.05M | $0.00 | 1 |
| Dec 2027 | $820.98M | $802.88M - $840.81M | -$141.80M | -$0.08 | 2 |
| Dec 2026 | $654.78M | $649.36M - $660.19M | -$113.10M | -$0.15 | 3 |
| Dec 2025 | $500.58M | $499.18M - $501.97M | -$86.46M | -$0.588 | 3 |
| Dec 2024 | $414.70M | $405.56M - $424.72M | -$71.63M | -$0.36 | 1 |
| Dec 2023 | $361.07M | $353.11M - $369.79M | -$62.37M | $0.00 | 1 |
| Dec 2022 | $245.76M | $239.44M - $255.94M | -$41.25M | -$0.28 | 1 |